
Joseph P. Martinez
Examiner (ID: 14796, Phone: (571)272-2335 , Office: P/2872 )
| Most Active Art Unit | 2872 |
| Art Unit(s) | 2872, 2873 |
| Total Applications | 1849 |
| Issued Applications | 1577 |
| Pending Applications | 86 |
| Abandoned Applications | 211 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11479340
[patent_doc_number] => 09585861
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-03-07
[patent_title] => 'Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents'
[patent_app_type] => utility
[patent_app_number] => 15/281735
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 40
[patent_no_of_words] => 15409
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15281735
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/281735 | Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents | Sep 29, 2016 | Issued |
Array
(
[id] => 11554119
[patent_doc_number] => 20170100365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'METHOD FOR TREATING PROSTATE CANCER AND/OR GASTROINTESTINAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/282636
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20216
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282636
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/282636 | Method for treating prostate cancer and/or gastrointestinal cancer | Sep 29, 2016 | Issued |
Array
(
[id] => 13476273
[patent_doc_number] => 20180289679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => TETRAHYDRO-1H-PYRIDO [3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
[patent_app_type] => utility
[patent_app_number] => 15/764988
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764988
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764988 | Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs | Sep 28, 2016 | Issued |
Array
(
[id] => 11499175
[patent_doc_number] => 20170073361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'GROUP 11 MONO-METALLIC PRECURSOR COMPOUNDS AND USE THEREOF IN METAL DEPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/274997
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 25054
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15274997
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/274997 | GROUP 11 MONO-METALLIC PRECURSOR COMPOUNDS AND USE THEREOF IN METAL DEPOSITION | Sep 22, 2016 | Abandoned |
Array
(
[id] => 16276707
[patent_doc_number] => 10759721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Deuterated CFTR potentiators
[patent_app_type] => utility
[patent_app_number] => 15/762264
[patent_app_country] => US
[patent_app_date] => 2016-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11959
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762264
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762264 | Deuterated CFTR potentiators | Sep 22, 2016 | Issued |
Array
(
[id] => 13901637
[patent_doc_number] => 20190040023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE
[patent_app_type] => utility
[patent_app_number] => 15/759600
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759600 | Modulators of indoleamine 2,3-dioxygenase | Sep 21, 2016 | Issued |
Array
(
[id] => 12509022
[patent_doc_number] => 10000457
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Process for preparing imidazolium based ionic liquids with di-polymerized oxirane base
[patent_app_type] => utility
[patent_app_number] => 15/273582
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3457
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273582
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273582 | Process for preparing imidazolium based ionic liquids with di-polymerized oxirane base | Sep 21, 2016 | Issued |
Array
(
[id] => 13916491
[patent_doc_number] => 10202352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Process for preparation of aminopyrazole
[patent_app_type] => utility
[patent_app_number] => 15/766271
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3708
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15766271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/766271 | Process for preparation of aminopyrazole | Sep 19, 2016 | Issued |
Array
(
[id] => 13618855
[patent_doc_number] => 20180360979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => BIOORTHOGONAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/759056
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759056
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759056 | Bioorthogonal compositions | Sep 11, 2016 | Issued |
Array
(
[id] => 13383407
[patent_doc_number] => 20180243245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => LRH-1 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/758549
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -59
[patent_words_short_claim] => 486
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758549
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758549 | LRH-1 modulators | Sep 8, 2016 | Issued |
Array
(
[id] => 11858938
[patent_doc_number] => 09738611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Dithiolene metal complex colorless IR absorbers'
[patent_app_type] => utility
[patent_app_number] => 15/255418
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2976
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255418
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/255418 | Dithiolene metal complex colorless IR absorbers | Sep 1, 2016 | Issued |
Array
(
[id] => 13440941
[patent_doc_number] => 20180272013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => 1,7-DIARYL-1,6-HEPTADIENE-3,5-DIONE DERIVATIVES, METHODS FOR THE PRODUCTION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/755166
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 728
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15755166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/755166 | 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof | Aug 25, 2016 | Issued |
Array
(
[id] => 13916989
[patent_doc_number] => 10202602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-12
[patent_title] => Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
[patent_app_type] => utility
[patent_app_number] => 15/247584
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 32051
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 625
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15247584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/247584 | Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups | Aug 24, 2016 | Issued |
Array
(
[id] => 13386183
[patent_doc_number] => 20180244633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => [4-(1,3,3-TRIMETHYL-2-OXO-3,4-DIHYDRO-1H-QUINOXALIN-7-YL)PHENOXY]ETHYLOXY COMPOUND OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/753410
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753410 | [4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereof | Aug 24, 2016 | Issued |
Array
(
[id] => 15193727
[patent_doc_number] => 10494342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Process for the preparation of apremilast
[patent_app_type] => utility
[patent_app_number] => 15/754067
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7293
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754067 | Process for the preparation of apremilast | Aug 21, 2016 | Issued |
Array
(
[id] => 16444830
[patent_doc_number] => 10836742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 15/751789
[patent_app_country] => US
[patent_app_date] => 2016-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25749
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751789
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751789 | N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals | Aug 10, 2016 | Issued |
Array
(
[id] => 11441829
[patent_doc_number] => 20170042848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK'
[patent_app_type] => utility
[patent_app_number] => 15/234941
[patent_app_country] => US
[patent_app_date] => 2016-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 54063
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15234941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/234941 | Biofilm inhibiting compositions enhancing weight gain in livestock | Aug 10, 2016 | Issued |
Array
(
[id] => 15540785
[patent_doc_number] => 10570157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/748557
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30634
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748557
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748557 | Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors | Jul 27, 2016 | Issued |
Array
(
[id] => 13328447
[patent_doc_number] => 20180215761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => TGF BETA RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/746597
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746597 | TGFb receptor antagonist | Jul 20, 2016 | Issued |
Array
(
[id] => 14326427
[patent_doc_number] => 10294217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators
[patent_app_type] => utility
[patent_app_number] => 15/758313
[patent_app_country] => US
[patent_app_date] => 2016-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15663
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15758313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/758313 | Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators | Jul 18, 2016 | Issued |